Harvard Bioscience
HBIO
HBIO
94 hedge funds and large institutions have $84.2M invested in Harvard Bioscience in 2024 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 33 increasing their positions, 27 reducing their positions, and 18 closing their positions.
Holders
94
Holders Change
-6
Holders Change %
-6%
% of All Funds
1.36%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
12
Increased
33
Reduced
27
Closed
18
Calls
$2K
Puts
$26K
Net Calls
-$24K
Net Calls Change
-$39K
Top Buyers
1 |
AE
1
AMH Equity
Great Neck,
New York
|
$6.43M |
2 |
HP
2
Harvey Partners
Tarrytown,
New York
|
$7.3M |
3 |
3
Goldman Sachs
New York
|
$472K |
4 |
PAM
4
Panagora Asset Management
Boston,
Massachusetts
|
$255K |
5 |
5
Morgan Stanley
New York
|
$431K |